Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
Clinical trial NCT05055609 · RECRUITING
Trial details
- NCT number
- NCT05055609
- Sponsor
- Trethera
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-23
- Primary completion
- 2026-12-31
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.